O. Merimsky et al., POSTOPERATIVE IRRADIATION COMBINED WITH CHEMOTHERAPY FOR HIGH-RISK RECTAL-CANCER PATIENTS - THE TIMING OF RADIOTHERAPY, Oncology Reports, 4(5), 1997, pp. 1093-1097
In a prospective open-study we evaluated the combination of radiation
therapy and adjuvant 5-FU plus levamisole in controlling Modified Astl
er-Coller (MAC) B2 or C rectal cancer following a curative-intended su
rgery. Sixty-four consecutive rectal cancer patients were treated by a
djuvant radiation therapy (Linac 8 MV, 50-50.4 Gy to an isocentric pel
vis brick volume in 5 fractions per week each of 1.8-2 Gy), and 12 mon
thly courses of 5-fluorouracil (375 mg/m(2)/day for 5 consecutive days
) plus levamisole (50 mg t.i.d. for 3 days). Within a median follow-up
period of 36 months, 19 patients (29.6%) experienced relapses. The 3-
year-DFS of MAC B2 patients was 82%, compared with 60% in MAC C. Early
radiation treatment was not associated with a higher proportion of re
lapses, while late radiation therapy initiation was associated with a
significantly higher proportion of relapses. Early radiation therapy,
not later than following the 2nd to 4th course of chemotherapy, is ass
ociated with the more acceptable proportion of relapses.